{"name": "BioAxone Therapeutic",
 "permalink": "bioaxone-therapeutic",
 "crunchbase_url": "http://www.crunchbase.com/company/bioaxone-therapeutic",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "514-282-9990",
 "description": "",
 "created_at": "Sat Jul 03 08:48:47 UTC 2010",
 "updated_at": "Sat Jul 03 08:53:57 UTC 2010",
 "overview": "\u003Cp\u003EBioAxone Therapeutic operates as a neuroscience company. The company specializes in the development and commercialization of proprietary technologies that target Rho signaling. It provides an experimental therapy for the treatment of neurological disorders. The company\u00e2\u20ac\u2122s product includes Cethrin for clinical trial for spinal cord injury. BioAxone Therapeutic was founded in 2000 and is based in Saint-Laurent, Canada.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$12.2M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.biospace.com/news_story.aspx?NewsEntityId=20142320",
    "source_description": "BioAxone Therapeutic Inc. Announces A Second-Round Investment Of $12.15 Million",
    "raised_amount": 12150000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 5,
    "funded_day": 20,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "T2C2 Capital",
         "permalink": "t2c2-capital",
         "image":
          {"available_sizes":
            [[[150,
               52],
              "assets/images/resized/0008/4403/84403v1-max-150x150.jpg"],
             [[154,
               54],
              "assets/images/resized/0008/4403/84403v1-max-250x250.jpg"],
             [[154,
               54],
              "assets/images/resized/0008/4403/84403v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Solidarity Fund QFL",
         "permalink": "solidarity-fund-qfl",
         "image":
          {"available_sizes":
            [[[150,
               77],
              "assets/images/resized/0003/2081/32081v1-max-150x150.png"],
             [[177,
               91],
              "assets/images/resized/0003/2081/32081v1-max-250x250.png"],
             [[177,
               91],
              "assets/images/resized/0003/2081/32081v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Desjardins Venture Capital",
         "permalink": "desjardins-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0002/3526/23526v1-max-150x150.jpg"],
             [[171,
               52],
              "assets/images/resized/0002/3526/23526v1-max-250x250.jpg"],
             [[171,
               52],
              "assets/images/resized/0002/3526/23526v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lothian Partners",
         "permalink": "lothian-partners",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "7150 rue Frederick-Banting",
    "address2": "Suite 200",
    "zip_code": "H4S 2A1",
    "city": "Saint-Laurent, QC",
    "state_code": null,
    "country_code": "CAN",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}